Gapinski D M, Mallett B E, Froelich L L, Jackson W T
Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, Indiana 46285.
J Med Chem. 1990 Oct;33(10):2798-807. doi: 10.1021/jm00172a019.
A series of lipophilic benzophenone dicarboxylic acid derivatives was prepared which inhibited the binding of the potent chemotaxin leukotriene B4 to its receptor(s) on intact human neutrophils. With a radioligand-binding assay as a measure of receptor affinity, a structure-activity relationship for this series was investigated. Both acidic residues were required for receptor-binding activity. The relative orientation of the two acidic groups was important for optimal binding. Replacement of the carbonyl group of the benzophenone with a variety of polar and nonpolar linking groups led to only small changes in binding affinity, indicating the linking group may not be involved in receptor recognition. Further structure-activity relationships within this series are reported in an accompanying paper.
制备了一系列亲脂性二苯甲酮二羧酸衍生物,它们能抑制强效趋化因子白三烯B4与其在完整人中性粒细胞上的受体的结合。采用放射性配体结合试验作为受体亲和力的衡量指标,研究了该系列化合物的构效关系。两个酸性残基对于受体结合活性都是必需的。两个酸性基团的相对取向对于最佳结合很重要。用各种极性和非极性连接基团取代二苯甲酮的羰基只会导致结合亲和力的微小变化,这表明连接基团可能不参与受体识别。该系列化合物进一步的构效关系在一篇配套论文中报道。